Retraction Note to: Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury [J Anesth, (2007), 21, 164-170, DOI 10.1007/s00540-006-0468-8];Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury

Journal of Anesthesia

Volumn 21, Issue 2, 2007, Pages 164-170

  Hagiwara, Satoshi ^a   Iwasaka, Hideo ^a   Noguchi, Takayuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Acute respiratory distress syndrome; Anticoagulant; LPS; Lung injury; Sepsis

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; NAFAMSTAT MESILATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; LEUKOCYTE; LUNG EDEMA; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; WISTAR RAT;

EID: 34247890064     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-015-2013-0     Document Type: Erratum

References (31)

1. GS Martin DM Mannino S Eaton M Moss 2003 The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 1546-1554 12700374 10.1056/NEJMoa022139
2. DL Wyncoll TW Evans 1999 Acute respiratory distress syndrome Lancet 354 497-501 10465189 10.1016/S0140-6736(98)08129-X 1:STN:280:DyaK1Mzpt1ymug%3D%3D
3. DL Hoyert RN Anderson 2001 Age-adjusted death rates: Trend data based on the year 2000 standard population Natl Vital Stat Rep 49 1-6
4. NC Riedemann RF Guo PA Ward 2003 The enigma of sepsis J Clin Invest 15 112 460-467 10.1172/JCI200319523
5. H Wang H Yang CJ Czura AE Sama KJ Tracey 2001 HMGB1 as a late mediator of lethal systemic inflammation Am J Respir Crit Care Med 164 1768-1773 11734424 1:STN:280:DC%2BD3Mnosl2lug%3D%3D
6. M Bustin 1999 Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins Mol Cell Biol 19 5237-5246 10409715 1:CAS:528:DyaK1MXkvVGqu7c%3D
7. H Wang O Bloom M Zhang JM Vishnubhakat M Ombrellino J Che A Frazier H Yang S Ivanova L Borovikova KR Manogue E Faist E Abraham J Andersson U Andersson PE Molina NN Abumrad A Sama KJ Tracey 1999 HMG-1 as a late mediator of endotoxin lethality in mice Science 285 248-251 10398600 10.1126/science.285.5425.248 1:CAS:528:DyaK1MXks1Sjtb0%3D
8. H Wang JM Vishnubhakat O Bloom M Zhang M Ombrellino A Sama KJ Tracey 1999 Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes Surgery 126 389-392 10455911 1:STN:280:DyaK1MzosVymsQ%3D%3D
9. U Andersson H Wang K Palmblad AC Aveberger O Bloom H Erlandsson-Harris A Janson R Kokkola M Zhang H Yang KJ Tracey 2000 High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 192 565-570 10952726 10.1084/jem.192.4.565 1:CAS:528:DC%2BD3cXlvFemsL0%3D
10. C Fiuza M Bustin S Talwar M Tropea E Gerstenberger JH Shelhamer AF Suffredini 2003 Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood 101 2652-2660 12456506 10.1182/ blood-2002-05-1300 1:CAS:528:DC%2BD3sXivVWgu7k%3D
11. E Abraham J Arcaroli A Carmody H Wang KJ Tracey 2000 HMGB1 as a mediator of acute lung inflammation J Immunol 165 2950-2954 10975801 1:CAS:528:DC%2BD3cXmslyns7g%3D
12. T Keck V Friebe AL Warshaw BA Antoniu G Waneck S Benz UT Hopt C Fernandez-del-Castillo 2005 Pancreatic proteases in serum induce leukocyte-endothelial adhesion and pancreatic microcirculatory failure Pancreatology 5 241-250 15855822 10.1159/000085278 1:CAS:528:DC%2BD2MXktVKqs7g%3D
13. S Noguchi M Nakatsuka H Konishi Y Kamada C Chekir T Kudo 2003 Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages Int Immunopharmacol 3 1335-1344 12890431 10.1016/ S1567-5769(03)00146-2 1:CAS:528:DC%2BD3sXlvVGru7g%3D
14. M Kirschfink 2001 Targeting complement in therapy Immunol Rev 180 177-189 11414360 10.1034/j.1600-065X.2001.1800116.x 1:CAS:528:DC%2BD3MXkvFegsLw%3D
15. M Uchiba K Okajima K Murakami H Okabe K Takatsuki 1997 Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats Am J Respir Crit Care Med 155 711-718 9032217 1:STN:280:ByiC1cvktFE%3D
16. H Ueno T Matsuda S Hashimoto F Amaya Y Kitamura M Tanaka A Kobayashi I Maruyama S Yamada N Hasegawa J Soejima H Koh A Ishizaka 2004 Contributions of high mobility group box protein in experimental and clinical acute lung injury Am J Respir Crit Care Med 170 1310-1316 15374839 10.1164/rccm.200402-188OC
17. H Wang H Yang KJ Tracey 2004 Extracellular role of HMGB1 in inflammation and sepsis J Intern Med 255 320-331 14871456 10.1111/ j.1365-2796.2003.01302.x 1:CAS:528:DC%2BD2cXislKmtbo%3D
18. R Kokkola A Andersson G Mullins T Ostberg CJ Treutiger B Arnold P Nawroth U Andersson RA Harris HE Harris 2005 RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages Scand J Immunol 61 1-9 15644117 10.1111/j.0300-9475.2005.01534.x 1:CAS:528:DC%2BD2MXhslGlu7s%3D
19. JS Park D Svetkauskaite Q He JY Kim D Strassheim A Ishizaka E Abraham 2004 Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 7370-7377 14660645 10.1074/jbc.M306793200 1:CAS:528:DC%2BD2cXhsFaqurc%3D
20. JE Kaplan AB Malik 1987 Thrombin-induced intravascular coagulation: Role in vascular injury Semin Thromb Hemost 13 398-415 3321435 1:CAS:528:DyaL1cXht12gtLk%3D
21. N Hasegawa AW Husari WT Hart TG Kandra TA Raffin 1994 Role of the coagulation system in ARDS Chest 105 268-277 8275746 1:STN:280:ByuC3c7pt1c%3D
22. K Okajima N Harada M Uchiba 2003 Microthrombus formation enhances tumor necrosis factor-alpha production in the development of ischemia/ reperfusion-induced liver injury in rats J Thromb Haemost 1 1316-1317 12871338 10.1046/j.1538-7836.2003.t01-2-00326.x 1:CAS:528:DC%2BD2cXktFOisLo%3D
23. T Aoyama Y Ino M Ozeki M Oda T Sato Y Koshiyama S Suzuki M Fujita 1984 Pharmacological studies of FUT-175, nafamostat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments Jpn J Pharmacol 35 203-227 6482087 1:CAS:528:DyaL2cXkvVemtb0%3D
24. EP Paques J Romisch 1991 Comparative study on the in vitro effectiveness of antithrombotic agents Thromb Res 64 11-21 1776137 10.1016/ 0049-3848(91)90201-7 1:CAS:528:DyaK3MXmslSgsLk%3D
25. T Yoshikawa M Murakami Y Furukawa H Kato S Takemura M Kondo 1983 Effects of FUT-175, a new systemic protease inhibitor, on endotoxin-induced disseminated intravascular coagulation in rats Homeostasis 13 374-378 1:STN:280:BiuC3szltVc%3D
26. B Dixon 2004 The role of microvascular thrombosis in sepsis Anaesth Intensive Care 32 619-629 15535483 1:STN:280:DC%2BD2crmtlKntQ%3D%3D
27. M Uchiba K Okajima K Murakami H Okabe K Takatsuki 1995 Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats Thromb Res 78 117-125 7482429 10.1016/0049-3848(95)00040-2 1:CAS:528:DyaK2MXltVags7k%3D
28. LB Ware MA Matthay 2000 The acute respiratory distress syndrome N Engl J Med 342 1334-1349 10793167 10.1056/NEJM200005043421806 1:STN:280:DC%2BD3c3jvFGhsw%3D%3D
29. H Sugita T Ishiko S Ikei M Hirota M Ogawa 1999 FUT-175 inhibits the production of IL-6 and IL-8 in human monocytes Res Commun Mol Pathol Pharmacol 103 57-64 10440571 1:CAS:528:DyaK1MXksVymt7k%3D
30. S Idell 2003 Coagulation, fibrinolysis, and fibrin deposition in acute lung injury Crit Care Med 31 4 Suppl S213-S220 12682443 10.1097/ 01.CCM.0000057846.21303.AB 1:CAS:528:DC%2BD3sXis12qtLs%3D
31. K Mellgren M Skogby LG Friberg L Tengborn H Wadenvik 1998 The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental extracorporeal life support (ECLS) Thromb Haemost 79 2 342-347 9493588 1:CAS:528:DyaK1cXhtVeis78%3D